Ferrer, Lanileah G.

HRN: 24-53-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2024
CEFUROXIME 1.5GM (VIAL)
04/01/2024
04/01/2024
IV
1.5grams
PTOR
For Diagnostic D&C
Checking Final Appropriateness 
03/31/2024
CEFUROXIME 500MG (TAB)
03/31/2024
04/07/2024
PO
500mg
BID X 7 Days
UTI
Waiting Final Action 
03/31/2024
CEFUROXIME 1.5GM (VIAL)
03/31/2024
04/01/2024
IV
1.5gms
Q8hrs
UTI
Waiting Final Action 
04/01/2024
CLINDAMYCIN 300MG (CAP)
04/01/2024
04/08/2024
PO
300mg
TID
S/p Manual Vacuum Aspiration Biopsy
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: